Award

Delivery Order #SPE2DP26F3200

Clindamycin Hydrochloride Delivery Order Awarded to DMS Pharmaceutical Group

Buyer

Defense Logistics Agency

Award Amount

$86.01

Ceiling

$86.01

Awarded

March 02, 2026

Period of Performance

Mar 02, 2026 – Mar 02, 2026

Identifier

SPE2DP26F3200

NAICS

424210

This award is a delivery order contract under an existing indefinite delivery vehicle, representing a focused pharmaceutical procurement effort. The recipient, DMS Pharmaceutical Group Inc., a distributor specializing in pharmaceutical products, will supply Clindamycin Hydrochloride, an important antibiotic medication. The contract ensures timely and reliable access to this essential drug, supporting federal health agencies' treatment protocols and broader public health goals. The scope of work covers the provision and delivery of this specific pharmaceutical product to a designated location in Park Ridge, Illinois, on the contract's effective date. This delivery order builds on a larger definitive pharmaceutical supply contract held by DMS Pharmaceutical Group, which includes a wide range of medical drugs to support diverse healthcare needs. The contract was awarded through the established indefinite delivery vehicle, suggesting a competitive and strategic procurement process. The specified performance is a short-term, single-day delivery, fitting within the ongoing overarching supply agreement.

Description

8511951849!CLINDAMYCIN HYDROCH

View original record